NVO logo

Novo Nordisk A/S (NVO) Non Current Assets

Annual Non Current Assets

$25.96 B
+$6.81 B+35.54%

31 December 2023

NVO Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$30.30 B
+$2.75 B+9.99%

30 September 2024

NVO Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.5%+35.5%
3 y3 years+98.5%+134.3%
5 y5 years+227.8%+236.2%

NVO Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+98.5%at high+134.3%
5 y5 yearsat high+227.8%at high+236.2%
alltimeall timeat high>+9999.0%at high>+9999.0%

Novo Nordisk A/S Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$30.30 B(+10.0%)
June 2024
-
$27.55 B(+4.3%)
Mar 2024
-
$26.40 B(+1.7%)
Dec 2023
$20.73 B(+33.1%)
$25.96 B(+16.1%)
Sept 2023
-
$22.36 B(+7.0%)
June 2023
-
$20.90 B(+4.9%)
Mar 2023
-
$19.92 B(+4.0%)
Dec 2022
$15.57 B(+19.5%)
$19.15 B(+17.5%)
Sept 2022
-
$16.30 B(+0.2%)
June 2022
-
$16.28 B(-1.9%)
Mar 2022
-
$16.60 B(+0.1%)
Dec 2021
$13.03 B(+19.8%)
$16.58 B(+28.2%)
Sept 2021
-
$12.93 B(-0.2%)
June 2021
-
$12.95 B(+2.7%)
Mar 2021
-
$12.61 B(-3.6%)
Dec 2020
$10.88 B(+16.2%)
$13.08 B(+25.1%)
Sept 2020
-
$10.45 B(+10.8%)
June 2020
-
$9.43 B(+1.3%)
Mar 2020
-
$9.31 B(-1.6%)
Dec 2019
$9.36 B(+3.5%)
$9.47 B(+5.0%)
Sept 2019
-
$9.01 B(-0.0%)
June 2019
-
$9.02 B(+4.5%)
Mar 2019
-
$8.63 B(+8.9%)
Dec 2018
$9.05 B(-6.5%)
$7.92 B(+6.6%)
Sept 2018
-
$7.43 B(+4.7%)
June 2018
-
$7.10 B(-1.6%)
Mar 2018
-
$7.22 B(+5.9%)
Dec 2017
$9.68 B(+13.9%)
$6.81 B(+5.5%)
Sept 2017
-
$6.46 B(+8.0%)
June 2017
-
$5.98 B(+7.9%)
Mar 2017
-
$5.54 B(+3.1%)
Dec 2016
$8.50 B(+5.2%)
$5.37 B(-0.2%)
Sept 2016
-
$5.38 B(+1.0%)
June 2016
-
$5.33 B(-2.6%)
Mar 2016
-
$5.47 B(+1.9%)
Dec 2015
$8.08 B(+6.9%)
$5.37 B(+5.6%)
Sept 2015
-
$5.08 B(-0.5%)
June 2015
-
$5.11 B(+3.6%)
Mar 2015
-
$4.93 B(-1.9%)
Dec 2014
$7.56 B(-2.9%)
$5.02 B(-2.1%)
Sept 2014
-
$5.13 B(-4.8%)
June 2014
-
$5.39 B(+1.9%)
Mar 2014
-
$5.29 B(+1.1%)
Dec 2013
$7.78 B(+9.4%)
$5.23 B(+6.3%)
Sept 2013
-
$4.93 B(+1.5%)
June 2013
-
$4.85 B(+5.9%)
Mar 2013
-
$4.58 B(+1.3%)
Dec 2012
$7.12 B(+3.2%)
$4.52 B(+1.5%)
Sept 2012
-
$4.45 B(+6.2%)
June 2012
-
$4.19 B(-5.7%)
Mar 2012
-
$4.45 B(+1.7%)
DateAnnualQuarterly
Dec 2011
$6.90 B(+3.7%)
$4.38 B(+3.2%)
Sept 2011
-
$4.24 B(-7.7%)
June 2011
-
$4.59 B(+3.0%)
Mar 2011
-
$4.45 B(+3.6%)
Dec 2010
$6.65 B(+5.9%)
$4.30 B(+1.2%)
Sept 2010
-
$4.25 B(+11.2%)
June 2010
-
$3.82 B(-7.5%)
Mar 2010
-
$4.13 B(-2.7%)
Dec 2009
$6.28 B(+14.9%)
$4.25 B(+0.0%)
Sept 2009
-
$4.25 B(+4.7%)
June 2009
-
$4.06 B(+5.9%)
Mar 2009
-
$3.83 B(-5.5%)
Dec 2008
$5.47 B(+14.9%)
$4.05 B(-1.7%)
Sept 2008
-
$4.12 B(-12.3%)
June 2008
-
$4.70 B(-2.2%)
Mar 2008
-
$4.81 B(+4.8%)
Dec 2007
$4.76 B(+29.1%)
$4.59 B(-4.7%)
Sept 2007
-
$4.81 B(+4.3%)
June 2007
-
$4.62 B(+8.2%)
Mar 2007
-
$4.27 B(+1.1%)
Dec 2006
$3.69 B(+19.0%)
$4.22 B(+6.8%)
Sept 2006
-
$3.95 B(+1.0%)
June 2006
-
$3.91 B(+7.4%)
Mar 2006
-
$3.64 B(+2.6%)
Dec 2005
$3.10 B(-4.8%)
$3.55 B(+0.1%)
Sept 2005
-
$3.54 B(+4.3%)
June 2005
-
$3.40 B(-3.3%)
Mar 2005
-
$3.51 B(-2.6%)
Dec 2004
$3.25 B(+18.0%)
$3.61 B(+13.5%)
Sept 2004
-
$3.18 B(+3.7%)
June 2004
-
$3.06 B(+0.5%)
Mar 2004
-
$3.05 B(-0.9%)
Dec 2003
$2.76 B(+42.0%)
$3.08 B(+23.1%)
Dec 2002
$1.94 B(+18.5%)
$2.50 B(+40.5%)
Dec 2001
$1.64 B(+4.9%)
$1.78 B(+18.2%)
Dec 2000
$1.56 B(-7.5%)
$1.50 B(+5.3%)
Dec 1999
$1.69 B(-17.4%)
$1.43 B(-36.1%)
Dec 1998
$2.05 B(+8.6%)
$2.24 B(+18.7%)
Dec 1997
$1.88 B(+1.9%)
$1.88 B(-0.9%)
Dec 1996
$1.85 B(+6.5%)
$1.90 B(+0.4%)
Dec 1995
$1.74 B(-20.0%)
$1.89 B(+45.3%)
Dec 1994
$2.17 B(+59.7%)
$1.30 B(-12.1%)
Dec 1993
$1.36 B(-19.6%)
$1.48 B(+49.7%)
Dec 1992
$1.69 B(+17.8%)
$990.68 M(-13.7%)
Dec 1991
$1.44 B(+25.0%)
$1.15 B(+13.2%)
Dec 1990
$1.15 B(+18.8%)
$1.01 B(+27.3%)
Dec 1989
$966.37 M(+36.0%)
$796.27 M(+26.4%)
Dec 1988
$710.80 M(+3.5%)
$629.89 M(-5.7%)
Dec 1987
$687.01 M(+16.1%)
$667.63 M(+29.1%)
Dec 1986
$591.69 M(+23.7%)
$517.16 M(+51.0%)
Dec 1985
$478.19 M(+24.8%)
$342.58 M(+45.0%)
Dec 1984
$383.03 M
$236.30 M

FAQ

  • What is Novo Nordisk A/S annual long term assets?
  • What is the all time high annual non current assets for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual non current assets year-on-year change?
  • What is Novo Nordisk A/S quarterly long term assets?
  • What is the all time high quarterly non current assets for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly non current assets year-on-year change?

What is Novo Nordisk A/S annual long term assets?

The current annual non current assets of NVO is $25.96 B

What is the all time high annual non current assets for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual long term assets is $25.96 B

What is Novo Nordisk A/S annual non current assets year-on-year change?

Over the past year, NVO annual long term assets has changed by +$6.81 B (+35.54%)

What is Novo Nordisk A/S quarterly long term assets?

The current quarterly non current assets of NVO is $30.30 B

What is the all time high quarterly non current assets for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly long term assets is $30.30 B

What is Novo Nordisk A/S quarterly non current assets year-on-year change?

Over the past year, NVO quarterly long term assets has changed by +$7.93 B (+35.48%)